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Abstract
Introduction: Retail drug sellers are a major source of health care and medicines in many countries. In Tanzania,
drug shops are widely used, particularly in rural and underserved areas. Previously, the shops were allowed to sell
only over-the-counter medicines, but sellers who were untrained and unqualified often illegally sold prescription
drugs of questionable quality.
Case description: In 2003, we worked with Tanzania’s Ministry of Health and Social Welfare to develop a public-private
partnership based on a holistic approach that builds the capacity of owners, dispensers, and institutions that regulate,
own, or work in retail drug shops. For shop owners and dispensers, this was achieved by combining training, business
incentives, supervision, and regulatory enforcement with efforts to increase client demand for and expectations
of quality products and services. The accredited drug dispensing outlet (ADDO) program’s goal is to improve
access to affordable, quality medicines and pharmaceutical services in retail drug outlets in rural or peri-urban
areas with few or no registered pharmacies. The case study characterizes how the ADDO program achieved
that goal based on the World Health Organization’s health system strengthening building blocks: 1) service
delivery, 2) health workforce, 3) health information systems, 4) access to essential medicines, 5) financing, and
6) leadership and governance.
Discussion and evaluation: The ADDO program has proven to be scalable, sustainable, and transferable: Tanzania
has rolled out the program nationwide; the ADDO program has been institutionalized as part of the country’s health
system; shops are profitable and meeting consumer demands; and the ADDO model has been adapted and
implemented in Uganda and Liberia. The critical element that was essential to the ADDO program’s success is
stakeholder engagement—the successful buy-in and sustained commitment came directly from the effort, time,
and resources spent to fully connect with vital stakeholders at all levels.
Conclusions: Beyond improving the quality of medicines and dispensing services, availability of essential medicines,
and the regulatory system, the impact of a nationwide accredited drug seller approach on the pharmaceutical sector
promises to provide a model framework for private-sector pharmaceutical delivery in the developing world that is
sustainable without ongoing donor support.
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Background
Private medicine retailers are principal players in promoting
access to medicines in low- and middle-income countries
[1]. For many years, drug shops and pharmacies have been
recognized for their potential to improve health across a
wide area of illnesses and health issues [2, 3]. A review of
literature looking at the role of drug sellers in child health
in Africa reported that caretakers’ use of retail drug outlets
for child illnesses ranged from 15 to 82 % with a median
around 50 %, and that they used retail outlets even when
cheaper alternatives existed, such as village health workers
[4]. In addition, drug shops are popular with the poorest
populations; in sub-Saharan Africa, for instance, 10.5 % of
people in the lowest wealth quintile sought primary care
from drug shops, compared to just 2.8 % of people in the
highest wealth quintile [5]. Despite their popularity and
potential, drug shops are not generally considered part of
the larger health system and are mostly missing from coun-
tries’ health strategies, policies, and monitoring.
Duka la Dawa Baridi in Tanzania
Prior to 2003, duka la dawa baridi constituted the largest
network of licensed outlets for basic essential medicines in
Tanzania. They were located in all of the country’s dis-
tricts, and their combined inventory turnover value was
estimated to be greater than Ministry of Health and Social
Welfare (MOHSW) expenditures on essential medicines
for primary health care [6]. Because full-service pharma-
cies are located almost exclusively in major urban areas
(60–70 % percent in Dar es Salaam alone), while approxi-
mately 75 % of Tanzanians live in rural and peri-urban
communities, duka la dawa baridi were often the most
convenient drug outlet [7].
Although important as a source of medicines for a sig-
nificant proportion of the population, data from a 2001
assessment [8] indicated that duka la dawa baridi were
associated with problems that included—
 Questionable medicine quality
 Inadequate storage for medicines
 Untrained staff
 Inadequate regulatory enforcement and supervision
 Authorization to sell only a limited list of over-the-
counter medicines
 Illegal dispensing of prescription medicines
Developing a public-private accreditation program
The Tanzania Food and Drugs Authority (TFDA), the ori-
ginal program champion, and Management Sciences for
Health, the technical partner, designed the accredited drug
dispensing outlet (ADDO) program to address these prob-
lems. The program’s goal was to improve access to afford-
able, quality medicines and pharmaceutical services in retail
drug outlets in rural or peri-urban areas with few or no
registered pharmacies.
To achieve that goal, we took a holistic approach that
combines changing the behavior and expectations of those
who use, own, regulate, or work in retail drug shops. For
shop owners and dispensing staff, this was achieved by
combining training, incentives, supervision, and regulatory
enforcement with efforts to affect customer demand
for and expectations of quality products and services.
Major program activities that contributed to this strat-
egy included—
 Developing accreditation based on government-
instituted standards and regulations
 Creating a public sector-based regulatory and
inspection system and strengthening local regulatory
processes and capacity
 Developing drug shop owners’ business skills
 Providing ADDO owners with business incentives,
such as access to microfinancing and legal
authorization to sell a limited list of essential
prescription medicines, including some antimicrobials
 Facilitating access to convenient and reliable sources
of quality medicines
 Changing behavior of dispensing staff through
training and supervision
 Improving awareness of customers regarding quality
and the importance of treatment compliance
through marketing and public education
Early evaluation results provided evidence that ADDOs
could improve access to quality pharmaceutical products
and services, and that a fully regulated, comprehensive
private sector pharmaceutical services system in Tanzania
could have a substantial impact on health care [6, 7]. While
acknowledging the significant costs and time needed for full
national implementation, the MOHSW and TFDA were
convinced that rolling out the ADDO program to all areas
of the country was warranted and that the broad societal
and health sector benefits justified the cost. Consequently,
the MOHSW approved scale-up of the ADDO concept
throughout mainland Tanzania and signaled its further
embrace of the program by announcing phase-out of all
unaccredited duka la dawa baridi by 2011.
The ADDO model is based on the assumption that to
effectively and sustainably tackle the problem of access1
to quality medicines and pharmaceutical services in a
resource-limited setting, all aspects of the drug shop
enterprise—the physical premises, medicine inventory
management, providers’ capacity and interactions with
consumers, and appropriateness of recommended treat-
ments according to national guidelines—must be addressed
comprehensively and systematically. In addition, the larger
pharmaceutical sector in which drug shops operate also
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needs to be strong and include product licensing and sup-
ply, training, record-keeping, reporting, and inspection.
The role of drug shops in the health system
The ADDO program is an interesting example of how to
use regulation “control knobs” to influence and structure
the performance of the retail private pharmaceutical sector
[9]. Because health systems vary widely depending on the
context, a best-practices model needs to be adapted for
local conditions. But health systems that function well share
certain characteristics: they have procurement and distribu-
tion systems that actually deliver medicines to those in
need; they are staffed with a sufficient number of skilled
and motivated health workers; and they operate with finan-
cing systems that are sustainable, inclusive, and fair—the
costs of health care should not force households into pov-
erty [10]. However, in sub-Saharan Africa, most public
health systems do not function effectively—the degree of
which depending on factors such as political stability, health
financing and infrastructure, management and oversight,
and availability of qualified personnel and commodities. As
a result, people commonly fill the void through the private
sector, which has received relatively little attention by
national and international policy makers.
Case study
This case study addresses the key study question: Is the
Tanzania ADDO model scalable, transferable, and sustain-
able?2 Specifically, it asks—
 Was the decentralized ADDO implementation
model effective in scaling up the ADDO program
nationally? What broader efforts helped to ensure
scalability?
 Was Tanzania’s ADDO model effectively adapted for
Ugandan and Liberian needs and replicated?
 Are accredited drug seller initiatives and their effects
sustainable without donor support?
This case draws data and information from an archive of
published and unpublished reports and studies including
results from our own data collection related to the ADDO
program. The initiative was piloted in the Ruvuma region
starting in 2003 and by mid-2013 had been rolled out to
every region in mainland Tanzania. The case study uses the
World Health Organization’s six health system building
blocks as a framework to characterize the ADDO program
and its contributions: 1) service delivery, 2) health work-
force, 3) health information systems, 4) access to essential
medicines, 5) financing, and 6) leadership and governance.
Service delivery
As the ADDO program took off, many recognized the
potential of these shops to not only increase access to
essential medicines, but also to serve as a platform for
community-based public health interventions; for example,
a child health training module for dispensers is based on
the Integrated Management of Childhood Illness initiative
and includes danger signs of pneumonia in children and
the appropriate action, co-trimoxazole treatment or refer-
ral, depending on the situation [11]. Other programs that
have been integrated include tuberculosis case identification
and referrals, distribution of subsidized artemisinin-based
combination therapies, and knowledge and control of
antimicrobial resistance [12–14]. Other public health inter-
ventions that are being pursued include creating a system
of referral linkages between community health workers,
ADDOs, and health facilities relating to maternal and child
health and family planning and the incorporation of rapid
diagnostic testing for malaria into ADDO services.
As a result of interest in the concept, numerous or-
ganizations and programs played a role in expanding
both the services that ADDOs provide and their geo-
graphic reach—over 9,000 accredited shops or shops
close to being accredited are currently serving the 25
regions of mainland Tanzania. And improvements have
been sustained: In 2010, 63 % of malaria encounters in
Ruvuma were treated according to the treatment
guidelines, compared to 24 % in 2004 (end of Ruvuma
pilot), and 6 % before the ADDO program started—a
950 % improvement [15] (Fig. 1). In addition, 301
people taking part in a household survey in Ruvuma
overall had a positive impression of ADDOs and
ADDO services (Table 1).
Health workforce
“This program complements the government efforts to
ensure that the communities get access to medicine. It
is more valid here in Namtumbo where public health
facilities are few in number and the district is facing a
real crisis of shortage of skilled health workers. I do not
know what would have been the situation without the
ADDOs. Our people depend on them” —District health
official, Namtumbo district, Ruvuma region [16].
Increased efforts to fight HIV/AIDS, malaria, and tuber-
culosis in sub-Saharan Africa have accentuated the critical
shortage of health care workers, including physicians,
nurses, and pharmacists. According to the World Health
Organization, Tanzania had about one pharmacy profes-
sional (pharmacist or pharmacy technician/assistant) for
every 100,000 people at the time the ADDO program
launched, with almost all working in urban areas [17].
Throughout Africa, programs have been testing innovative
approaches to ease the health care personnel shortage
[18, 19].
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ADDO Dispenser Curriculum Topics
Rutta and colleagues [16] described how the government
of Tanzania addressed a lack of access to quality medicines
and services by creating a new cadre of pharmaceutical
service provider based in ADDOs. Although many inter-
ventions targeting retail drug sellers have been carried out
in Africa and Asia, they usually have focused singularly on
training or other capacity-building activities and have often
been limited to a particular concern, such as malaria or
child health [20, 21]. Because of its comprehensive ap-
proach to addressing public and private sector issues as well
as consumer demand, the ADDO program not only fills a
human resource niche in the health system, but can also be
a career pathway for dispensers.
As the text box illustrates, in addition to appropriate
dispensing, training also focuses on the importance of
record-keeping. Owners and dispensers learn how to
monitor product sales, keep track of expiry dates, and
what types of products to stock to improve business. In a
survey of owners and dispensers after accreditation, almost
all reported keeping financial records (94 %) and monitor-
ing daily sales (98 %); in addition, 69 % tracked monthly
profits [22]. Although the program design included owners’
incentives to become accredited, such as an expanded list
of allowable drugs to stock, in our surveys, owners have
repeatedly mentioned dispenser training as the most highly
valued program benefit. Tanzania now has over 20,000
dispensers trained with the government-approved curricula.
This equates to approximately 43 trained personnel per
100,000 population.
Another important feature is the program’s impact on
women—particularly rural women who have few employ-
ment options. By the time the last region was rolled out in
mid-2013, approximately 90 % of ADDO dispensers and
39 % of ADDO owners were women. This program, there-
fore, provides a unique opportunity for many women to
supplement their family’s income, while at the same time
taking on a leadership role within their community.
Health information systems
As mentioned, ADDO owners and dispensers are trained
to keep records related to business and sales. Dispensers
track who buys medicines (in addition to select demo-
graphic information) and for what conditions. The avail-
ability of such records at ADDOs has allowed supervision
and inspection teams to review and assess ADDO
dispensers’ performance and the shops’ compliance with
regulations. The records provide information that could
not only help health officials quickly identify problems,
such as epidemics, but could also provide surveillance
information on common conditions in the community.
However, these data are generally not easily communi-
cated and are therefore not reported to health authorities.
In addition, the regulatory authority (now the Pharmacy
Council3) needed more efficient ways to track activities
related to ADDOs and pharmacies, such as premises loca-
tion, inspection dates, license renewal, and accreditation
status.
Fig. 1 Percentage of encounters with appropriate malaria treatment in intervention and control regions: 2003–2010
• Laws, regulations, and ethics
• Good dispensing practices and rational medicines use
• Common medical conditions in the community
• Reproductive health and HIV/AIDS
• Communication skills and counseling
• Child health
• Record-keeping
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To help improve information access, we worked with a
local technology firm, Invention and Technological Ideas
Development Organization (ITIDO), to build a web-based
regulatory database and website for the Pharmacy Council.
The database uses unique identification numbers for
ADDOs and pharmacies as well as for all personnel. ITIDO
trained Pharmacy Council staff on maintenance and use of
the database and handed over to them the necessary equip-
ment. We also trained Pharmacy Council staff in how to
use GPS devices to geo-code premises and Google Earth
maps to locate the geo-coded ADDOs and pharmacies.
Our research had shown that most ADDO owners and
dispensers have basic mobile phones. ITIDO developed
mobile applications for payment, indicator reporting, and
information exchange through an SMS-based helpline
between ADDOs and Pharmacy Council that does not
require smart phones. We piloted the full mobile package
in Pwani region and the mobile payment component in
Pwani and Dar es Salaam. Of 140 ADDOs in the pilot, an
average of 80 % regularly reported on eight indicators, such
as drug availability, using mobile phones from May through
August, 2014. During that time, Pharmacy Council received
3,378 messages on the SMS-helpline and sent out 22,818
messages to ADDOs, pharmacies, and pharmacy profes-
sionals. Table 2 shows two months’ worth of data from
Pwani region on ADDO service statistics on child health
and family planning.
Incorporating information technology including mobile
money and other applications has a potentially major im-
pact on drug seller initiatives’ sustainability. Dispensers have
had no trouble reporting basic service statistics, and during
the pilot, 129 people used mobile money to pay over 12
million TSH in fees. Shop personnel appreciate the ease of
paying fees through M-Pesa: “This system is good. In the
past I had to close my shop and go all the way to the Coun-
cil, and there you might find a long queue and sometimes
you spend the whole day there” (Dispenser, Kibaha) [23]. In
addition, ADDO staff felt that it was much easier to get
information through the new SMS-based helpline, although
as the number of inquiries has increased, the Pharmacy
Council is needing to develop and adhere to procedures for
responding on a timely basis. Additionally, our evaluation
showed that the Pharmacy Council required more coaching
on how to take advantage of the information; although
personnel knew how to access the data, it was not being
used for decision-making. Orienting MOHSW officials to
the newly available private sector data will likely increase
demand for it.
Access to essential medicines
For many common medical problems, such as malaria and
diarrhea, a variety of factors lead people to self-diagnose
and medicate before visiting a government health facility:
distance to the health facility; lack of drug availability in the
public facility; cash availability; and customer concerns
about privacy and quality of the health care, facilities, and
medicines [21, 24, 25].
Medicine quality
People were buying prescription-only medicines from
drug shops in Tanzania long before shops were accredited,
but they were being sold illicitly by untrained staff. Ac-
creditation standards have broadened the list of medicines
ADDOs can legally dispense to include basic essential
medicines—both prescription and nonprescription—and
required training on appropriate medicine use and refer-
ral. In addition, consumers who buy medicines in ADDOs
can be assured that the quality is better because standards
have improved drug storage and management practices.
In our initial evaluation, we used drug registration status
as a proxy indicator for the quality of drugs being sold in
shops. After accreditation, the proportion of unregistered
medicines in Ruvuma was reduced by a factor of 13, from
26 to 2 % [7]. In evaluations in other regions since then,
no unregistered products have been found in ADDOs,
and our recent research showed that 93 % of 243 drug
samples passed quality tests [26]. ADDO dispensers also
receive training on the importance of not selling drugs
that have expired, and our research has indicated that
expiry is no longer a major problem in the shops.
Medicine policies
The ADDO program has acted as a catalyst to drive
the creation of new policies related to improving ac-
cess to medicines in the private sector, including the
Table 2 Mobile phone-based indicator reporting in Pwani
region (July–August 2014)
# Total clients attended 57,528
# Under 5 years attended 17,082
# Under 5 with malaria 9,138
# Under 5 with pneumonia 3,786
# Under 5 with diarrhea 3,792
# Under 5 referred 1,356
# Clients receiving oral contraceptive pills 7,464
Table 1 Household opinions of ADDOs in Ruvuma: 2010
Opinion % (n = 301)
Obtains most medicines from ADDOs 86
ADDOs improve quality of care 84
Drug shop is clean and tidy 79
Attendant is knowledgeable 79
Medicines are available 76
Medicines are of good quality 68
Prices are affordable 46
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2009 MOHSW notice to phase out unaccredited drug
shops by 2011, the establishment of the Medicine Access
Steering Committee under the MOHSW to coordinate
access initiatives in the private sector, and the National
Malaria Control Program’s 2006 adoption of the ADDO
platform as part of its strategy to increase access to malaria
treatment, which paved the way for ADDOs to distribute
subsidized artemisinin‐based combination therapy. Other
significant policies include the incorporation of child health
services into the ADDOs in 2006 and the National Health
Insurance Fund decision to allow members to fill prescrip-
tions at ADDOs in 2007. These pharmaceutical sector
policies have strengthened Tanzanians’ access to essential
medicines.
Medicine availability
As noted, one of the primary reasons that people choose
ADDOs over health facilities is the more consistent avail-
ability of popular medicines. Accreditation increased the
legal availability of some prescription-only medicines; in
addition, our research has shown that ADDOs generally
have better stock of medicines on hand for children. In our
audit of 95 ADDOs and 72 health facilities in four regions
in 2013, the availability of capsules and tablets in ADDOs
and health facilities was similar, however, ADDOs had sig-
nificantly better availability of suspensions and syrups,
which are commonly prescribed to treat young chil-
dren (p = 0.009).
ADDOs also continue to be included in strategies to
increase community availability to treatment for childhood
conditions. After neonatal causes, pneumonia (21 %) and
diarrhea (17 %) are the leading causes of childhood mor-
tality in Tanzania—both imminently treatable conditions
[27]. In line with a number of relevant global initiatives,
we have recently begun partnering with UNICEF to
improve community access to new products to treat child-
hood pneumonia and diarrhea—amoxicillin dispersible
tablets and oral rehydration solution (ORS)/zinc co-packs.
UNICEF is working to increase access in the public sector,
while our intervention will target 700 ADDOs in 12 dis-
tricts to stock the two new commodities. Our activities
include orienting owners and dispensers on how to man-
age and dispense the products and monitoring the avail-
ability through a mobile phone application.
Financing
Developing and implementing an accredited drug seller
initiative and bringing it to scale requires committed
resources, individuals, and institutions. The initial funding
for the conceptualization and pilot of the ADDO program
in Ruvuma came from the Gates Foundation, but multiple
stakeholders contributed to the program rollout and
enhancement (Table 3). After the centrally implemented
pilot program, we worked with stakeholders to decentralize
implementation by using district-level teams that worked
simultaneously in multiple regions, rather than having one
national team covering one region at a time (Fig. 2). To
further increase efficiency and reduce costs, the revised
model’s dispenser training schedule was reduced from 45
to 30 days and shop mapping and preliminary inspection
activities were merged. When the implementation model
shifted responsibility from central to local authorities, the
rollout time decreased from an estimated 18 months to
less than 12 months per region, and TFDA records indi-
cated that the estimated implementation cost fell by 55 %
(126,000 USD per district compared with 57,000 USD per
district).
Once the ADDO program was established, the primary
financing issue shifted to shop profitability and program
maintenance—private sector shops need to stay in business
and cover their costs and the public sector could not rely
on ongoing donor contributions to fund program mainten-
ance costs.
Shop profitability
From the start of the program, accredited shops have been
profitable. Although the pilot program in Ruvuma linked
the majority of owners with microfinance institutions to
help them make the improvements needed to become
accredited, few owners in other regions used that option to
finance their shop renovations or operations. The majority
of owners (79 %) reinvested their ADDO business profits;
11 % tapped personal savings for business financial needs;
and 8 % used a combination of financing options [22].
Evidence of profitability also came from the willingness of
owners and dispensers to take over all costs associated with
accreditation, which had previously been donor funded.
Additionally, when the National Health Insurance Fund
incorporated ADDOs into its scheme, owners felt that the
arrangement boosted their sales.
We compared results of interviews with Ruvuma shop
owners during our pilot’s endline evaluation in 2004 and
then again in 2010. Those data show that none of the
owners reported making no profit in either year (Fig. 3).
Compared to 2004, where a majority of ADDOs (62 %)
made a profit of less than 50,000 TZS per month, in the
2010 survey, only 26 % claimed that they made less than
50,000 TZS, while 44 % reported making a net monthly
profit of 100,000 to 500,000 TZS which is two to ten times
higher. Note that the value of the TZS was about 30 % less
in 2004 compared with 2010 (~1,087 TZS to 1 USD in
2004 compared with ~1,430 TZS to 1 USD in 2010).
Program maintenance costs
In 2008 the government mandated local governments to
include oversight of the ADDO program in their budgets.
At the central level, ADDO maintenance costs are part of
the annual budgets of both the Pharmacy Council and the
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Table 3 ADDO program milestones: 2003–2013
ADDO program phase Year Description
Assessment, program design, conceptualization
and planning
2001–2003 The Strategies for Enhancing Access to Medicines (SEAM) Program, MOHSW, TFDA, and
multisectoral stakeholders assessed access to essential medicines, recommended a
public-private sector approach to improving access, and designed and reached a
consensus on the ADDO model with Ruvuma as a pilot region. Program funding
provided by the Bill & Melinda Gates Foundation.
Pilot program development and
implementation—Ruvuma region
2003–2005 SEAM Program and TFDA design and launch the ADDO program in the Ruvuma
region—210 outlets accredited. (Gates Foundation).
Private sector contribution (210 owners’ investment for premises construction or
upgrade to meet accreditation standards).
Pilot program M&E 2003–2005 SEAM commissioned monitoring and evaluation of the ADDO program in Ruvuma
(Gates Foundation).
2006 Danida sponsored an independent evaluation of the ADDO program in Ruvuma by HERA.
Program scale-up (centralized approach) 2006–2008 Government of Tanzania, through the MOHSW, approves TFDA plan to rollout ADDOs
to Tanzanian mainland.
U.S. Agency for International Development (USAID), through MSH’s Rational Pharmaceutical
Management Plus Program, funds ADDO rollout in Morogoro region using resources from
the President’s Emergency Plan for AIDS Relief—553 ADDOs.
Government of Tanzania funds rollout in Mtwara and Rukwa regions—122 ADDOs.
Private sector contribution (675 owners costs investment for premises construction or
upgrade to meet accreditation standards) in Morogoro, Rukwa, and Mtwara.
2007–2008 Danida supports TFDA to conduct training of trainers and district inspectors, develop
and print training materials used for scale-up, and carry out national sensitization
seminars with local governments.
Program scale-up (decentralized approach) 2007–2011 Gates Foundation funds the East African Drug Seller Initiative (EADSI) to work with TFDA to
review and revise the existing ADDO model to make nationwide scale-up more cost-
efficient and to help ensure the long-term sustainability of ADDOs and to evaluate effect
of changes made on access to medicines and quality of products and services provided.
2008 Tanzanian stakeholders agreed to decentralize implementation model to improve efficiency
of scale-up and sustainability of program at consensus meetings in Dodoma and Morogoro.
2008 Global Fund to Fight AIDS, Tuberculosis and Malaria agrees to fund ADDO rollout in six
to eight high-impact malaria regions to improve access to antimalarials for children
under five; Danida and government of Tanzania also contribute funding for rollout.
2009 Clinton Health Access Initiative funds initial implementation activities in Shinyanga and
Dodoma
2008–2009 Local governments in Shinyanga, Tabora, Iringa, Arusha, Kagera, and Kilimanjaro took
initiative on their own to mobilize funds to introduce ADDOs.
2011 Cost of training in Dar es Salaam for the urban ADDO model funded by ADDO
dispenser and owner contributions (~1,300 dispensers and ~1,700 owners).
2013 Last region, Mwanza, launches the ADDO program in June 2013. Officially, ADDO
program coverage is nationwide.
Program maintenance and sustainability;
public health intervention integration into
the ADDO program
2006 National Malaria Control Programme adopts the ADDO concept as part of its national
strategy to increase access to malaria treatment.
2006 MSH’s Rational Pharmaceutical Management Plus Program collaborates with the Basic
Support for Institutionalizing Child Survival Project to add a child health component to
ADDO services (USAID funded FY07, FY08, FY09).
2007 Tanzania’s National Health Insurance Fund initiates plan that allows members to fill
prescriptions at ADDOs.
2007 MSH’s Strengthening Pharmaceutical Services Program uses President’s Malaria Initiative
funds to provide subsidized artemisinin-based combination therapy through ADDOs
(FY06, FY07, FY08).
2008 The Prime Minister’s Office for Regional Administration and Local Government mandates
local governments to incorporate ADDO program implementation into their planning
and budgets.
2009 Rockefeller Foundation funds MSH to develop a strategy to promote program sustainability
and quality through the establishment of ADDO owner and dispenser associations.
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TFDA. Government funding is supplemented by the annual
license fees paid by pharmacies and ADDOs, which has
increased along with program scale-up and as the Phar-
macy Council has improved its ability to track payments
using its database. The launch of the mobile money appli-
cation also makes it easier for pharmacy and ADDO staff
to pay fees to the Pharmacy Council.
Medicine sales prices
Our data have shown that average drug prices generally
increase more in ADDO intervention regions immediately
after implementation compared to control regions. This
supports the assertion that ADDO owners tend to recoup
some of their expenses by raising prices after incurring
significant expenses in renovations, training, and inventory.
To assess if the price increase is a temporary or permanent
phenomena, we compared 2010 prices of select tracer items
in Ruvuma to the 2004 prices by normalizing them with
international prices. The average median price for a market
basket of antibiotics compared with MSH’s International
Drug Price Indicator Guide showed virtually no difference
between 2004 and 2010 (+15 % compared with +16 %).
Median prices in Ruvuma compared to the international
price guide increased 1 % between 2004 and 2010 after
adjusting for inflation. In addition, our recent research in
four regions showed that the average price for a tracer list
of medicines at 86 ADDOs was only 15 % more than the
tracer list average at 98 public health facilities.
Institutionalized training
Stakeholders in Tanzania identified the institutionalization
of training as a critical step toward independence from
donor funding. In preparation for public and private train-
ing institutions to take over from the program (i.e., Man-
agement Sciences for Health and the national regulatory
authority), we developed criteria for selecting training insti-
tutions and assessed the choices available in Tanzania and
in Uganda, where we had also launched an accreditation
program. We identified seven institutions in Tanzania—one
for each zone: Lake, Northern, Central, Southern High-
lands, Southern, Western, and Eastern. All seven have
carried out ADDO dispenser training with costs ranging
from 270,000 to 350,000 TZS per person (~150–200 USD).
Separate courses and fees for business training are being
Table 3 ADDO program milestones: 2003–2013 (Continued)
2009 Government of Tanzania regulation is revised to phase out unaccredited drug shops
(duka la dawa baridi) by 2011.
2011 Legislative change mandates the transition of program oversight from TFDA to
Pharmacy Council.
2010–2012 As a pilot, MSH’s Systems for Improved Access to Pharmaceuticals and Services Program
collaborates with National TB and Leprosy Control Program to integrate interventions to
engage 550 ADDOs in Morogoro to improve early detection of people with TB symptoms
(USAID).
2011–2015 Gates Foundation funds the Sustainable Drug Seller Initiative to ensure the maintenance
and sustainability of these public-private drug seller initiatives in Tanzania and Uganda
and to introduce and roll out the initiative in Liberia.
Fig. 2 Evolution of ADDO implementation model in Tanzania
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implemented—this six-day business training costs in the
range of 70,000 to 100,000 TZS per person (~40–
56 USD). In Uganda, we selected two training institutions
to deliver the first institutionalized seller and owner train-
ings, one located in an eastern district and one in a west-
ern district. Fort Portal International Nursing School
completed its first training in March 2014 for 65 partici-
pants at a cost of 600,000 UGX (~240 USD) per partici-
pant. Since then, the school has trained 402 sellers in four
additional districts in western Uganda. The school’s faculty
delivered some of the drug seller courses within the dis-
tricts themselves as opposed to holding them at their main
campus in Fort Portal. This reduced travel costs and other
expenses for the trainees and significantly increased
course demand, which benefited the school financially.
Tanzania’s Pharmacy Council is responsible for the insti-
tutions’ training standards and oversight, and it issued a
notice to all districts that ADDO trainings will now be
conducted exclusively through approved training institu-
tions, with ADDO owners and dispensers covering all
costs. The Pharmaceutical Society of Uganda, which works
with the National Council on Higher Education, now has
responsibility for reviewing and updating the accredited
drug shop curriculum as needed; it also accredits the
training institutions.
Leadership and governance
Development of the accreditation standards was a critical
part of the model design that led to the overhaul of regula-
tions governing duka la dawa baridi operations. TFDA
technical committees reviewed and approved draft stan-
dards before the MOHSW approved them and the Minis-
ter signed them. Table 4 summarizes the standards for
accreditation, which covers areas such as inspection. The
development of the ADDO standards and code of ethics
resulted from a comprehensive, wide-ranging stakeholder
consultation process; nearly 400 people participated, in-
cluding regional and district medical officers, members of
Parliament, councilors, and duka la dawa baridi owners.
The law requires all ADDO owners and dispensers to have
a thorough understanding of these standards and ethics.4
It was amended in 2009 to accommodate the revision of
the model to reflect decentralized implementation and
operations—most notably, inspections.5
Local oversight
As the program expanded, it quickly became clear that a
centralized TFDA did not have the capacity to continue
implementing the rollout in new regions while overseeing
the existing program. Therefore, as mentioned, an import-
ant aspect of revising the model was to decentralize the
implementation and oversight responsibility to the district
level. Although a national-level champion is key to a
successful model launch, a mature program relies on the
commitment of local officials to support inspection and
program maintenance; consequently, 3,262 district and
ward inspectors have been trained as part of the initiative.
Empowering provider associations
In addition to the government’s role in overseeing ADDO
operations, we worked to strengthen existing professional
drug shop provider associations and facilitate the formation
of new provider associations to serve as a governance
resource and a professional “voice” for the owners and
dispensers. This work produced an association toolkit that
was developed through a consultative stakeholder work-
shop [28]. It includes operational and management tools
(available in English and Kiswahili) related to how to form
Fig. 3 Average monthly net profit reported by ADDOs (TZS) in Ruvuma region: 2004–2010
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and register and association, mobilize financial resources,
and monitor and evaluate activities.
After a national mapping exercise identified 35 associa-
tions, we chose four model districts to serve as learning
grounds (Bagamoyo, Kilombero, Mbinga, and Mbarali).
After orientation workshops, each association received sup-
port to develop a three-year activity plan. Some of these
activities included peer-peer supervision (Mbarali), income-
generating activities such as land purchase (Mbarali), and
establishment of savings and credit societies (Bagamoyo).
As association services have increased, membership has
grown and membership fees collected have doubled.
To evaluate this work, we interviewed owners and dis-
pensers on their perceptions of how membership in an
association can help them individually. ADDO owners said
they expect the associations to—
 Give them a strong unified voice on matters relating
to their businesses
 Help them access loans to improve their
businesses
 Enable them to have joint procurement of drugs
and other pharmaceutical products and enjoy the
economies of scale resulting from bulk purchases
 Provide them with a platform to engage with various
authorities such as Pharmacy Council, Tanzania
Revenue Authority, and local government authorities
 Create a forum for them to share experiences and
resolve conflicts among members
 Enable them to pool resources to start their own
savings and credit cooperative societies and advance
loans to members
 Provide them with a mechanism for self-regulation
to minimize noncompliance with pharmaceutical
sector regulations and standards
Likewise, dispensers mentioned that the associations
will—
 Provide them with a platform to deliberate on issues
of interest
 Give them a common voice to air grievances to
owners
 Help them demand better salaries and work
conditions, including standard working hours,
overtime payment, and annual leave
 Provide them with a forum to exchange ideas and
experiences in line with their training and enable
Table 4 ADDO program standards for accreditation
Component Process or requirements
Accreditation application
process
A Council Food and Drug Committee is responsible for a four-part application process for shops: an application
form, initial inspection of the existing facility, re-inspection after any premise upgrades required for accreditation,
and ongoing inspection after accreditation.
Incentives for owners Owner incentives focus on improved shop profitability and approval to sell a range of prescription medications.
Incentives for owners who commit to standards include access to micro-financing for stock purchases, a marketing
campaign encouraging consumers to buy medicines at ADDO, and more reliable sources of affordable, quality
wholesale goods.
Premises infrastructure The standards provide instructions for building size, layout, identification, dispensing and services areas, storage,
and security.
Staff qualification The grade levels of ADDO dispensers include nurses, nurse-midwives, clinical officers, assistant medical officers,
pharmaceutical assistants, and pharmaceutical technicians. The most common qualification of ADDO dispensers
prior to ADDO training is nurse assistant.
Training All dispensers must be accredited by the TFDA, display their accreditation certificate, and have their photo
identification on their coats when working. Accreditation involves completing a TFDA-approved dispensers’ course.
Course topics include in-depth information on ADDO drugs in their generic and brand forms; illness indications
and contraindications; drug dosages, side effects, and patient information; laws governing dispensers’ work; basic
management, record-keeping, and business ethics; and communications skills. ADDO training for shop owners
focuses on ethics, regulations, and improvement of business management skills.
Drug quality and availability The ADDO list of approved pharmaceuticals includes a full range of over-the-counter drugs and a limited list of
prescription drugs, including common antibiotics and oral contraceptives. ADDOs may sell only those drugs
registered with and approved by the TFDA. ADDO-restricted wholesalers can receive a license to sell
nonprescription and ADDO-restricted approved prescription drugs under the supervision of a full-time
pharmaceutical wholesaler’s technician.
Record keeping ADDOs must keep records of all prescription drugs sold and their selling prices, financial and sales information,
customer complaints, and expired medications. These records may be used for supervision purposes and must be
available for review by inspectors.
Regulation, inspection,
and sanctions
Local government officials receive a basic inspection training course from the TFDA and are certified as local
inspectors. They work with the TFDA to conduct a minimum of two inspections of each shop annually. The
program also carries out inspections of remaining unaccredited shops, and can issue sanctions against those that
illegally sell prescription drugs. A channel exists for registering any customers’ complaints against ADDOs or any
shops’ complaints about harassment by inspectors or other problems.
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them to improve their skills and promote
self-compliance to regulations
 Enable them to pool resources and invest in other
income-generating activities toward a goal of
individual development and self-improvement
Peer supervision
A challenge with the accreditation model has been
providing regular supportive supervision to dispensers.
While local officials periodically inspect shops to ensure
compliance with standards, they do not have the time or
resources to make more frequent supervisory visits. There-
fore, a notable activity was the development of association-
based peer-peer supervision in Ugandan Accredited Drug
Shops (ADS) in Mityana district. Since the peer supervision
started in October 2013, peers who were nominated by
their associations have made supervisory visits every two to
three months. In turn, those peer supervisors received sup-
port from the association leadership and the regional
Pharmaceutical Society of Uganda representative and tech-
nical team. Peer supervisors helped the ADS sellers with is-
sues related to taking steps to improve their performance,
rational medicine use, use of rapid diagnostic tests, patient
referral, quantification of supplies, dispensing equipment,
and self-assessments.
A pre/post evaluation of Mityana with Kyenjojo district
serving as a control found that ADS in both districts expe-
rienced improvements in various indicators including
management of common conditions, dispensing practices,
and product availability. However, Table 5 shows Mityana’s
more robust results related to management of simple
diarrhea in children. We see peer supervision organized
through provider associations as a sustainable way to com-
plement local government supervision and inspection.
Introducing and growing health-related consumer advocacy
Also in Uganda, we collaborated with the Coalition for
Health Promotion and Social Development (HEPS) to cre-
ate and implement a consumer advocacy strategy related to
expectations about pharmaceutical services and rights
regarding health care. HEPS implemented the strategy in
Kamuli district by training community leaders and outreach
volunteers to attend community events to talk about the
public’s health rights, what services the public should
expect from drug shops, and rational medicine use. As a
result, awareness of medicines issues in the community
increased. “The community members now ask the drug
sellers important questions about medicine packaging and
handling which was not there before,” one volunteer in
Nawanyago said [29]. The district community development
officer heard many local leaders caution people on medi-
cines use at meetings he attended in villages and parishes.
Community cognizance about drug shops also resulted in
changes; for example, after receiving public pressure, an
unqualified drug shop owner switched from selling medi-
cines to selling clothes in Balawoli sub-county, and in
Kitayunjwa, a general merchandise shop quit selling medi-
cines. HEPS has been approached to carry out similar
consumer advocacy initiatives in other districts that other
donors will fund.
Discussion and evaluation
"One thing is certain, informal providers represent a
growing and undeniable force within the health
community, and despite the refusal of some
governments and others to acknowledge/engage with
them, it is in all our interests—particularly the
patients—to begin working more effectively with these
elusive actors"—Tom Feeny, HANSHEP [30].
The goal of the ADDO program has been to improve
access to affordable, quality medicines and pharmaceutical
services in retail drug outlets in rural or peri-urban areas
where there are few or no registered pharmacies. To
achieve this goal, the ADDO model took a holistic ap-
proach that combines developing the capacity of owners,
dispensers, and institutions that regulate or work in retail
drug shops. For shop owners and dispensing staff, this has
been achieved by combining training, incentives, supervi-
sion, and regulatory enforcement with efforts to affect
client demand for and expectations of quality products and
services. Figure 4 illustrates the drug seller initiative con-
ceptual framework.
Stakeholder engagement: the linchpin of success
The primary element that has been essential to the ADDO
program’s success is stakeholder engagement—the suc-
cessful buy-in and sustained commitment came directly
from the effort, time, and resources spent to fully connect
with all vital stakeholders at all levels. Involvement ranged
from publicly stating support for the concept to working
Table 5 Peer supervision effect on management of non-bloody diarrhea in Ugandan children
Category of children Mityana before Mityana after Kyenjonjo before Kyenjonjo after
Presented with non-bloody diarrhea 129 348 62 21
Received zinc and ORS 83/129 (64 %) 330/348 (95 %) 42/62 (68 %) 16/21 (76 %)
Received oral antibiotics 27/129 (21 %) 23/348 (7 %) 29/62 (47 %) 12/21 (57 %)
Referred 6 1 2 0
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closely on all aspects of the program design and imple-
mentation. At the end of the pilot in Ruvuma, regional
and district stakeholders reported the following program
strengths: use of a participatory approach that involved all
stakeholders from the beginning: owners, dispensers, con-
sumers, political leaders; a fair and transparent process for
permit application and approvals; the dispenser training
component; and respecting and valuing community-level
inputs [7].
During the program’s critical early period, TFDA in
collaboration with MOHSW organized a study visit of
members of Parliament’s Social Welfare Committee to
ADDOs in Ruvuma. Their enthusiastic reaction paved the
way for the allocation of additional funding for rollout
from the government. In her budget presentation to the
Parliament in 2004, the Minister of Health, Hon. Anna
Abdallah, reported that 1.06 million USD had been allo-
cated to expand the ADDO program following the prom-
ising results from the pilot in Ruvuma. Such a high-level
commitment of the government’s own budget provided an
incentive for continued donor interest and support, which
is illustrated in the list of program milestones (Table 3).
Another sign of government ownership was the various
strategic documents that started addressing the ADDO
program as a “key MOHSW program” and not a “donor-
funded project.” For example in the Ministry’s Health Sector
Strategic Plan III July 2009–June 2015: Partnership for
Delivering the MDGs, the ADDO program was cited as
fundamental in the private sector provision of essential
medicines to vulnerable groups [31, 32].
The purpose of this case report was to answer questions
related to the scalability, transferability, and sustainability
of the Tanzania ADDO model specifically, but also the
accredited drug seller initiative in general.
Scalability of the Tanzanian ADDO model
Funded by the government of Tanzania and multiple
development partners over a decade-plus period, Tanzania’s
ADDO program achieved nationwide scale-up in June
2013. The time needed to mobilize the funding and regula-
tory capacity delayed scale-up from the government’s
original 2011 target. From the proof-of-concept pilot in
Ruvuma region in 2003 through scale-up, the ADDO pro-
gram evolved to address public health needs and economic
Fig. 4 Accredited drug seller initiative conceptual framework
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realities. As mentioned, the estimated implementation cost
decreased by 55 % from decentralization and incorporating
efficiencies in training; in addition, as owners and dis-
pensers realized the benefits of accreditation, they became
more willing to pay for accreditation costs, such as brand-
ing, renovations, increased inventories, and training that
had been covered by donors in the program’s early years.
The shift of implementation to the districts from the
central level also allowed quicker scale-up because multiple
regions could be scaled up simultaneously—while it took
Tanzania six years to roll out the ADDO program in four
regions under the original centralized model, 10 more
regions completed implementation within three years
using the decentralized approach.
Transferability of the ADDO model to other country
contexts
We have demonstrated the extent to which the ADDO
model can be transferred and replicated in other countries’
settings through the establishment of ADS in Uganda and
Accredited Medicine Stores (AMS) in Liberia. Management
Sciences for Health worked with national and local stake-
holders to develop an accreditation model based on the
Tanzanian experiences, but adapted to the two countries’
different needs and health and pharmaceutical sectors.
Liberia, especially, offered a unique opportunity because of
its status as a post conflict state and our shift of focus to an
urban rather than rural setting.
As of July 2015 in Uganda and Liberia, 689 and 313
shops, respectively, were accredited or awaiting accredit-
ation, and 1,330 sellers had been trained in Uganda and
664 in Liberia. Both countries have developed scale-up
strategies that will phase out the current class of unaccred-
ited shops. Liberia also changed its regulations to formalize
AMS as part of Liberia’s health care delivery system. In both
countries, evaluations showed that ADS and AMS in-
creased the availability of quality pharmaceutical products
and improved dispensing and business skills. For example,
the percentage of ADS offering injections, which are illegal
in drug shops in Uganda, fell from 74 % to 0 after accredit-
ation in the pilot district. In Liberia, the percentage of
expired, damaged, or counterfeit products on the shelves of
drug shops went from 28 % at baseline to 8 % at endline,
while the percentage of owners keeping business records
rose from 33 % at baseline to 80 to 90 % over three moni-
toring periods after the intervention.
Sustainability of the ADDO model
Our goal was to ensure the maintenance and sustainability
of public-private drug seller initiatives that increase access
to and appropriate use of quality pharmaceutical products
and services for common conditions in underserved popu-
lations. Several model components focus specifically on
increasing efficiency and thereby contributing to program
sustainability and independence from donor funding. They
include the following—
 Incorporating technology, including mobile money
and SMS-based reporting, to facilitate payments and
communication between the shops and the
regulatory body
 Strengthening shop owner/dispenser associations to
empower providers to govern themselves through
peer-supervision and create mechanisms to boost
members’ financial sustainability
 Empowering the community to increase demand for
quality pharmaceutical services and products
 Institutionalizing training by shifting the
responsibility and costs from the public to the
private sector
Conclusions
Using the World Health Organization’s health system
building blocks as a framework, this case study demon-
strates that the creation of a public-private partnership
using government accreditation to increase access to qual-
ity pharmaceutical products and services in underserved
areas of Tanzania was scalable, sustainable, and transfer-
able. The primary means to success was stakeholder buy-
in and ownership—the country must drive the activity,
not the donor or the organization providing technical
support. However, implementing an accredited drug seller
program is complex, with political, legal, regulatory, pro-
fessional practice, and economic challenges to address.
Consequently, developing an initiative and bringing it to
scale is an expensive venture. If limited funding is available
and used to complete only discrete pieces of what is
needed to create a sustainable whole, then failure can
result if interest wanes or the situation changes before all
pieces can be completed.
Through our initial work in Tanzania and then in Uganda
and Liberia, we have expanded access to medicines and
treatment, but also solidified the global view that public-
private initiatives to strengthen the quality of pharmaceut-
ical products and services provided by retail drug sellers are
feasible and effective in multiple settings. The impact of the
ADDO approach on the pharmaceutical sector—and on so-
ciety as a whole—promises to provide a model framework
for private-sector pharmaceutical delivery in the developing
world.
Endnotes
1We define access to medicines by physical availability,
affordability, geographic accessibility, and acceptability
(or satisfaction).
2Scalable defined as the ability to expand an intervention
to support larger system without affecting performance;
transferable defined as extent to which an intervention can
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be replicated and implemented in a new country; sustain-
able defined as persistence of the intervention’s effect over
time.
3Until 2011, TFDA was the regulatory authority respon-
sible for ADDOs; however, a regulatory change placed the
responsibility with the Pharmacy Council.
4The Tanzania Food, Drug and Cosmetics Act (standard
and code of Ethics for Duka la Dawa Muhimu Regulation
2004.
5The Tanzania Food, Drug and Cosmetics Act (stand-
ard and code of Ethics for Duka la Dawa Muhimu
(Amendments) Regulation 2009.
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